Autopsy report · NCT00979186

A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance

“Study Terminated - No enrollment, business decision.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Ethicon Endo-Surgery

Sponsor type

Industry

Conditions

Cholecystectomy

Interventions

NOTES GEN 1 Toolbox

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
  “Study terminated due to low enrollment.” (88% match in meaning)
• BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
  “Study was terminated due to low enrollment.” (86% match in meaning)
• A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
  “The study was terminated due to low enrollment.” (84% match in meaning)
• Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
  “Study terminated for business reasons” (84% match in meaning)
• Virtue® Male Sling Fixation Study
  “The study has been terminated due to lack of subject enrollment.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.